MATTEO
FRASSON -
CONTRATADO/A DOCTOR/A
ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Publicaciones en las que colabora con ANDRES MANUEL R CERVANTES RUIPEREZ (9)
2023
-
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer
Colorectal Disease, Vol. 25, Núm. 6, pp. 1135-1143
2020
-
Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database
Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 63-72
2019
-
Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer
Diseases of the Colon and Rectum, Vol. 62, Núm. 6, pp. 684-693
2018
-
Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score
Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2
2017
-
Stents metálicos autoexpandibles como puente a la cirugía en el tratamiento del cáncer de colon izquierdo en oclusión. Análisis coste-beneficio y resultados oncológicos
Cirugia Espanola, Vol. 95, Núm. 3, pp. 143-151
2015
-
Selective approach for upper rectal cancer treatment: Total mesorectal excision and preoperative chemoradiation are seldom necessary
Diseases of the Colon and Rectum, Vol. 58, Núm. 6, pp. 556-565
2012
-
Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: What is the impact on lymph node harvest after colon resection for cancer?
Diseases of the Colon and Rectum, Vol. 55, Núm. 2, pp. 197-204
-
T4a and T4b Colorectal cancer: What does this mean nowadays
Diseases of the Colon and Rectum
2011
-
Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer
Cancer, Vol. 117, Núm. 14, pp. 3118-3125